Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9540343 Compounds for the treatment of HIV

Patent 9540343 was granted and assigned to Gilead Sciences on January, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Gilead Sciences
Gilead Sciences
Date Filed
July 5, 2012
Date of Patent
January 10, 2017
Patent Application Number
14130882
Patent Citations Received
‌
US Patent 12122765 Methods and intermediates for preparing therapeutic compounds
0
‌
US Patent 12077537 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 12084467 Therapeutic compounds for HIV virus infection
0
‌
US Patent 12091405 Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
0
‌
US Patent 11685728 Capsid inhibitors for the prevention of HIV
0
‌
US Patent 11680064 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11753399 Therapeutic compounds
‌
US Patent 11760746 Methods and intermediates for preparing therapeutic compounds
‌
US Patent 11787825 Therapeutic compounds for HIV virus infection
‌
US Patent 11833143 Choline salt forms of an HIV capsid inhibitor
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9540343
Patent Primary Examiner
‌
Jean Cornet

Find more entities like US Patent 9540343 Compounds for the treatment of HIV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.